Warning letterFDA · Mar 28, 2022
NDAL Mfg Inc. MARCS-CMS 621656, March 28, 2022
Named company: NDAL Mfg Inc.
This warning letter summarizes significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals. Because your methods, facilities, or controls for manufacturing,…
Lot information: not specified in this record.